These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7718296)
1. [Determination of plasminogen activator of the head and neck tumor tissue]. Ji X; Nong H; Huang G Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(5):299-301. PubMed ID: 7718296 [TBL] [Abstract][Full Text] [Related]
2. Relationship between head and neck squamous cell carcinomas and fibrinolytic factors. Immunohistological study. Itaya T; Suzuki K; Takagi I; Motai H; Baba S Acta Otolaryngol Suppl; 1996; 525():113-9. PubMed ID: 8908283 [TBL] [Abstract][Full Text] [Related]
3. [Usefulness of neuron specific enolase in patients with head and neck malignant tumors]. Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M Pol Merkur Lekarski; 2002 Mar; 12(69):204-7. PubMed ID: 12053589 [TBL] [Abstract][Full Text] [Related]
4. In vitro urokinase type plasminogen activator levels and total plasminogen activator activity in squamous cell carcinomas of the head and neck. Petruzzelli GJ; Snyderman CH; Johnson JT Arch Otolaryngol Head Neck Surg; 1994 Sep; 120(9):989-92. PubMed ID: 8074827 [TBL] [Abstract][Full Text] [Related]
5. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma. Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505 [TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. Albo D; Tuszynski GP J Surg Res; 2004 Jul; 120(1):21-6. PubMed ID: 15172186 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma. Hofmann R; Lehmer A; Buresch M; Hartung R; Ulm K Cancer; 1996 Aug; 78(3):487-92. PubMed ID: 8697395 [TBL] [Abstract][Full Text] [Related]
8. [Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck]. Somekawa Y; Asano K; Taira A; Imai R Gan To Kagaku Ryoho; 1996 Jan; 23(1):75-9. PubMed ID: 8546473 [TBL] [Abstract][Full Text] [Related]
9. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070 [TBL] [Abstract][Full Text] [Related]
10. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma. Mannello F Cancer; 2003 Jan; 97(1):201-3; author reply 203-4. PubMed ID: 12491521 [No Abstract] [Full Text] [Related]
11. Cathepsin D and PAI-1 expression in human head and neck cancer. Zeillinger R; Eder S; Schneeberger C; Ullrich R; Speiser P; Swoboda H Anticancer Res; 1996; 16(1):449-53. PubMed ID: 8615652 [TBL] [Abstract][Full Text] [Related]
12. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Andruchow JL; Veness MJ; Morgan GJ; Gao K; Clifford A; Shannon KF; Poulsen M; Kenny L; Palme CE; Gullane P; Morris C; Mendenhall WM; Patel KN; Shah JP; O'Brien CJ Cancer; 2006 Mar; 106(5):1078-83. PubMed ID: 16444748 [TBL] [Abstract][Full Text] [Related]
13. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339 [TBL] [Abstract][Full Text] [Related]
14. Urokinase receptor up-regulation in head and neck squamous cell carcinoma. Schmidt M; Schler G; Gruensfelder P; Müller J; Hoppe F Head Neck; 2000 Aug; 22(5):498-504. PubMed ID: 10897110 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck. Milanovich MR; Snyderman CH; Wagner R; Johnson JT Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915 [TBL] [Abstract][Full Text] [Related]
17. Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases. Salzman R; Kanková K; Pácal L; Tomandl J; Horáková Z; Kostrica R Neoplasma; 2007; 54(4):321-5. PubMed ID: 17822322 [TBL] [Abstract][Full Text] [Related]
18. Ornithine decarboxylase activity in tumor and normal tissue of head and neck cancer patients. Weiss RL; Calhoun KH; Ahmed AE; Stanley D Laryngoscope; 1992 Aug; 102(8):855-7. PubMed ID: 1495349 [TBL] [Abstract][Full Text] [Related]
19. Multiple forms of plasminogen activator in human breast tumors. O'Grady P; Lijnen HR; Duffy MJ Cancer Res; 1985 Dec; 45(12 Pt 1):6216-8. PubMed ID: 3933824 [TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Festuccia C; Vincentini C; di Pasquale AB; Aceto G; Zazzeroni F; Miano L; Bologna M Oncol Res; 1995; 7(3-4):131-8. PubMed ID: 8555646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]